Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Mathematical Biology|February 26, 2014
Optimization of an amplification protocol for misfolded proteins by using relaxed controlJean-Michel Coron, Pierre Gabriel, Peipei Shang
Computational and Mathematical Methods in Medicine|May 13, 2022
Therapeutic Effect and Prognosis of Biliary Tract Tumor TransformationPeiPei Shang, Yong Yu, PeiNing Yan, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 17, 2026
AURKB drives aggressive phenotype and clinicopathological progression in cholangiocarcinomaMinglong Wang, Peipei Shang, Yanxi Luo, et al.
Journal of Environmental Management|June 23, 2023
Natural gas spot price prediction research under the background of Russia-Ukraine conflict - based on FS-GA-SVR hybrid modelYunan Zheng, Jian Luo, Jinbiao Chen, et al.
Environmental Science and Pollution Research International|August 10, 2019
Feasibility of peaking carbon emissions of the power sector in China's eight regions: decomposition, decoupling, and prediction analysisYong Wang, Xuelian Su, Lin Qi, et al.
The Journal of International Medical Research|November 2, 2023
Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case reportPeipei Shang, Cheng Lou, Lei Yin, et al.
Frontiers in Oncology|July 6, 2023
RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancerPeipei Shang, Jiongjiong Lu, Feihong Song, et al.
The Science of the Total Environment|November 19, 2018
Interregional carbon compensation cost forecast and priority index calculation based on the theoretical carbon deficit: China as a caseGuangchun Yang, Peipei Shang, Lichun He, et al.
Frontiers in Pharmacology|July 1, 2024
Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responsesYizhou Wang, Peipei Shang, Chang Xu, et al.
Frontiers in Oncology|December 12, 2024
Superior survival benefits of triple combination immunotherapy compared to standard chemotherapy as second-line treatment for advanced biliary tract cancer: a retrospective analysisPeipei Shang, Heming Xu, Tianmei Zeng, et al.
Pageof 2